C3 glomerulopathy: What's in a name

Kidney International

Volumn 82, Issue 4, 2012, Pages 379-381

  D'Agati, Vivette D ^a   Bomback, Andrew S ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN; MEMBRANE COFACTOR PROTEIN;

ANTIGEN ANTIBODY COMPLEX; C3 GLOMERULOPATHY; CLINICAL FEATURE; COMPLEMENT DEPOSITION; DISEASE ACTIVITY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; GENE; GLOMERULOPATHY; HUMAN; IMMUNOFLUORESCENCE; MEMBRANE COFACTOR PROTEIN GENE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; SYNDROME DELINEATION;

EID: 84864560528     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.80     Document Type: Note

References (12)

1. Levy M, Gubler MC, Sich M e t al. Immunopathology of membranoproliferative glomerulonephritis with subendothelial deposits (Type 1 MPGN). C lin Immunol Immunopathol 1978; 1 0: 4 77-4 92.
2. Habib R, Gubler M-C, Loirat C e t al. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. Kidney Int 1975; 7 : 204-215.
3. Strife CF, McEnery PT, McAdams AJ e t al. Membranoproliferative glomerulonephritis with disruption of the glomerular basement membrane. C lin Nephrol 1977; 7 : 6 5-7 2.
4. Appel GB, Cook HT, Hageman G e t al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. J Am Soc Nephrol 2005; 16: 1392-1 403.
5. Servais A, Fremeaux-Bacchi V, Lequintrec M et al. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome. J Med Genet 2007; 4 4: 1 93-1 99.
6. Sethi S, Fervenza FC. Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 2011; 3 1: 3 41-3 48.
7. Servais A, Noël L-H, Roumenina LT et al. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. K idney Int 2012; 8 2: 4 54-4 63.
8. Sethi S, Fervenza FC, Zhang Y e t al. C3 glomerulonephritis: clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up. Kidney Int 2012; 82 : 465-473.
9. Zhang Y, Meyer NC, Wang K e t al. Causes of alternative pathway dysregulation in dense deposit disease. C lin J Am Soc Nephrol 2012; 7 : 2 65-2 74.
10. Bao L, Haas M, Quigg RJ. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol 2011; 2 2: 2 85-2 95.
11. Gharavi AG, Kiryluk K, Choi M e t al. Genome-wide association study identifies susceptibility loci for IgA nephropathy. N at Genet 2011; 4 3: 3 21-3 27.
12. Fremeaux-Bacchi V, Weiss L, Demouchy C e t al. Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor C3NeF IgG autoantibody activity. Nephrol Dial Transplant 1994; 9 : 1 747-1 750.